8103 related articles for article (PubMed ID: 2437862)
21. [Possibilities and limits of the use of interferons in the clinic].
Ludwig CU
Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
[TBL] [Abstract][Full Text] [Related]
22. The role of interferons in the treatment of hematologic malignancies.
Gutterman JU
Semin Hematol; 1988 Jul; 25(3 Suppl 3):3-8. PubMed ID: 2459780
[TBL] [Abstract][Full Text] [Related]
23. [Clinical experience with alpha and beta interferon in childhood cancer].
Ise T; Ohira M; Takayama J; Hanada M; Muchi H; Fukuma H; Beppu Y; Nomura K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1855-62. PubMed ID: 6591860
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
Ezaki K
Gan No Rinsho; 1983 May; 29(6):598-602. PubMed ID: 6308306
[No Abstract] [Full Text] [Related]
25. [Clinical trial of human lymphoblastoid interferon on advanced malignancy].
Usui N; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Miyamoto H; Ikeda K; Nakada H; Adachi K; Okada Y
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2324-9. PubMed ID: 6357102
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
27. Alpha interferon therapy for renal cell carcinoma: summary of four collaborative trials. Cancer Research Committee.
Aso Y; Umeda T; Niijima T
Prog Clin Biol Res; 1989; 303():653-9. PubMed ID: 2675017
[No Abstract] [Full Text] [Related]
28. [Antitumor effect of interferons].
Ebina T; Saito M
Gan To Kagaku Ryoho; 1984 Jan; 11(1):24-35. PubMed ID: 6421241
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval TI; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; de Vassal F; Horoszewicz JP
Biomed Pharmacother; 1982; 36(3):167-70. PubMed ID: 6758874
[TBL] [Abstract][Full Text] [Related]
30. The role of interferons in the treatment of malignant neoplasms.
Murren JR; Buzaid AC
Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
[TBL] [Abstract][Full Text] [Related]
31. The role of interferon in the therapy of malignant lymphoma.
McLaughlin P
Biomed Pharmacother; 1996; 50(3-4):140-8. PubMed ID: 8881370
[TBL] [Abstract][Full Text] [Related]
32. [Interferon-alpha, beta, gamma].
Imanishi J
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2853-8. PubMed ID: 7993128
[TBL] [Abstract][Full Text] [Related]
33. Interferons: not just alpha.
Krown SE
Cancer Treat Rep; 1986 Dec; 70(12):1353-5. PubMed ID: 2431773
[No Abstract] [Full Text] [Related]
34. [New immunotherapy methods for cancer. II. Anti-tumour mechanisms of interferon (IFN)-gamma analysed in an adult T cell leukemia patient with remarkable tumor regression].
Makidono R; Koga S; Fukuya T; Omagari J; Tomooka K; Hayabuchi N; Jingu K; Matsuura K
Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Jan; 46(1):27-37. PubMed ID: 3010226
[No Abstract] [Full Text] [Related]
35. [Clinical study on the effect of natural alpha-interferon (HLBI) in the treatment of adult T-cell leukemia].
Ichimaru M; Kamihira S; Moriuchi Y; Kuraishi Y; Usui N; Toki H; Okabe K; Niho Y; Shibuya T; Umei T
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2975-81. PubMed ID: 3052302
[TBL] [Abstract][Full Text] [Related]
36. [Interferons in the treatment of solid tumors. A general review].
Dorval T; Pouillart P
Bull Cancer; 1988; 75(9):885-8. PubMed ID: 2462946
[TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
38. [Introduction of natural interferon-alpha "Sumiferon"].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2800-3. PubMed ID: 3631977
[TBL] [Abstract][Full Text] [Related]
39. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
[TBL] [Abstract][Full Text] [Related]
40. [Local application of interferon beta to skin lesions of malignant melanoma and malignant lymphoma--clinical and histopathological analysis].
Ito Y; Jimbow K; Miura S; Maeda K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1263-8. PubMed ID: 6732253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
